Elona Baum From CIRM to Speak at the Stem Cell Summit - April 2013 in Boston, MA

Monrovia, California (PressExposure) March 12, 2013 -- Elona Baum, General Counsel & Vice President of Business Development at the California Institute of Regenerative Medicine will present on "Strategic Partnerships in Stem Cell Research & Regenerative Medicine" at the Stem Cell Summit 2013 (Apr 29-30, 2013 in Boston, MA)

This discussion will cover partnering strategies in the regenerative medicine and stem cell field, including early pharma investments and current trends. In addition, Elona Baum will address the CIRM Strategic Partnership Funding Initiative.

Elona Baum is the General Counsel and Vice President of Business Development for the California Institute for Regenerative Medicine (CIRM). She is an experienced attorney with more than 20 years of practice, mostly in the life sciences and drug development field. As a member of CIRM's executive team, Ms. Baum is responsible for the strategic initiatives of the agency, as well as overall management of the legal function.

We invite you to attend the 10th Stem Cell Summit taking place on April 29-30, 2013 in Boston, MA. This summit includes two concurrent tracks including a few joint sessions. This summit provides cutting-edge information on developments in all areas of stem cell research including the biology, medicine, applications, regulations, and the business of Stem Cells.

Recent developments in pre-clinical and clinical trials of stem cell therapy, regenerative medicine and tissue engineering, cancer stem cells, stem cell reprogramming, and regulatory policies regarding stem cell research will be addressed. In addition, focuses on the business opportunities, challenges and potential strategies for overcoming these challenges will be addressed. What categories of companies are currently commercially viable? How are they being funded? What kind of strategic relationships are available within the industry?

The 2013 Stem Cell Summit includes two parallel tracks. This summit provides cutting-edge information on developments in all areas of stem cell research including the biology, medicine, applications, regulations, and commercialization of stem cells.

Track A: Stem Cell Research & Regenerative Medicine:
Joint Session: Funding Opportunities
Joint Session: Regulatory Guidance & Updates
Session: Advances in iPS & ES Cells
Session: Advances in Adult Stem Cells
Session: New Paradigms for Cell Therapy

Track B: Stem Cell Commercialization & Partnering:
Joint Session: Funding Opportunities
Joint Session: Regulatory Guidance & Update
Session: Novel Technologies in Stem Cell Research
Session: Overcoming Challenges in Clinical Development
Session: Commercialization: Bringing Therapeutics to Market
Session: Partnerships & Acquisitions

Summit Agenda: http://www.gtcbio.com/stemcellsummit/agenda
Summit Speaker List: http://www.gtcbio.com/stemcellsummit/speakers
For more information, please visit http://www.gtcbio.com

About GTC Conferences

GTC organizes conferences specifically for the biomedical and biopharmaceutical industries. Our goal is to facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic and government organizations, and the financial community.


GTC (Global Technology Community), LLC, is a privately held company founded in 2002.

Press Release Source: http://PressExposure.com/PR/GTC_Conferences.html

Press Release Submitted On: March 12, 2013 at 3:40 am
This article has been viewed 25293 time(s).